Skip to main content

Baxalta Vs. AbbVie: Biopharma Spin-Off Battle

Baxter and Abbott both have very long dividend histories. Their new spin-offs intend to pay ever-increasing dividends as well. The question is, what company makes the better long-term investment?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.